Physician profile
Tilu Thomas
NPI 1639839103
$296.76
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $158 · 2023: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.88 | 2022-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $52.57 | 2022-2023 | Gattex, Entyvio |
| Abbvie INC. | $52.33 | 2022-2023 | |
| Ardelyx, INC. | $23.92 | 2022 | |
| Braintree Laboratories, INC. | $17.84 | 2023 | Sutab |
| Regeneron Healthcare Solutions, INC. | $16.99 | 2023 | Dupixent |
| Nestle Healthcare Nutrition INC. | $14.29 | 2023 | |
| Merck Sharp & Dohme LLC | $14.06 | 2023 | Zinplava, Dificid |
| Intercept Pharmaceuticals, INC. | $11.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tilu Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.